Jessica Baker Flechtner

Jessica Baker Flechtner is the current Chief Scientific Officer at Genocea Biosciences. Jessica has over 20 years of experience in the field of immunology and has worked at several prestigious institutions, including the Dana-Farber Cancer Institute/Harvard Medical School and Cornell University.

Jessica's research has focused on understanding how the immune system works and how it can be modulated to treat various diseases. In their role as Chief Scientific Officer at Genocea, they are responsible for leading the company's scientific and technical team in the development of new vaccines and immunotherapies.

Jessica has authored numerous papers on their research findings and has been recognized as an expert in their field. Jessica is a member of several professional organizations, including the American Association of Immunologists and the American Society for Microbiology.

Jessica Baker Flechtner has a PhD in Cellular Immunology from Cornell University and a BS in Animal Science from Cornell University.

Jessica Baker Flechtner works with Jacquelyn Sumer - Chief Legal & Compliance Officer, Raymond D. Stapleton - Chief Technology Officer, and Girish Aakalu - Chief Business Officer. Their manager is Chip Clark, President & CEO.